Power your ovarian cancer studies with our telomerase-immortalized metastatic CAFs, designed to mirror the aggressive stromal environment of advanced-stage disease. These cells preserve the defining characteristics of peritoneal spread, maintaining stable expression of FAP, LOXL2, and CA-125 along with robust ECM remodeling capabilities through multiple passages.
Power your ovarian cancer studies with our telomerase-immortalized metastatic CAFs, designed to mirror the aggressive stromal environment of advanced-stage disease. These cells preserve the defining characteristics of peritoneal spread, maintaining stable expression of FAP, LOXL2, and CA-125 along with robust ECM remodeling capabilities through multiple passages.